Superficial Basal Cell Carcinoma: In-House Trial

  • Men and women 18 years of age and older
  • Ameluz and photodynamic therapy compared to placebo and photodynamic therapy
  • Presence of at least 1 naïve sBCC lesion on the face/forehead, bald scalp, extremities, and/or neck/trunk
  • Up to 4 treatments; study varies on response

***We are currently conducting this study as an in-house patient trial, and are not accepting study sign-ups at this time.

Volunteer for this study!

  • This field is for validation purposes and should be left unchanged.